Physician profile
Patrick William Kenney
NPI 1134620149
$1,663.52
in general payments reported to CMS, 2019-2025
7 companies · $740 in 2025
The $740 reported for 2025 was more than what 80% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $150 · 2022: $155 · 2023: $245 · 2024: $374 · 2025: $740.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,359.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,358.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,150.45 | 2022-2025 | General - Pain Management, Wavewriter Alpha Prime 16, Na |
| Medtronic, INC. | $301.54 | 2024-2025 | Inceptiv, Synchromedii, Intellis Adaptivestim |
| Stryker Corporation | $95.98 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $68.94 | 2021-2022 | |
| Axsome Therapeutics, INC. | $17.02 | 2023 | Sunosi |
| Horizon Therapeutics Plc | $15.40 | 2021 | |
| Averitas Pharma INC. | $14.19 | 2023 | Qutenza |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Kenney listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.